Mindray Expands Its Cardiac Biomarker Portfolio with Cutting-Edge hs-cTnI and NT-proBNP Assays, Empowering Enhanced Cardiovascular Diseases Care

SHENZHEN, China, Oct. 23, 2023 /PRNewswire/ -- Mindray (SZSE: 300760), a global leader in medical devices and solutions, introduces high-sensitivi...

Related Keywords

China ,Shenzhen ,Guangdong ,Wuhan ,Hubei ,Prnewswire Mindray ,Hennepin Healthcare Research Institute ,Acute Coronary Syndrome ,Wuhan Asian Heart Hospital ,Tni Assay ,Chief Scientific Officer ,Patient Monitoring ,Life Support ,In Vitro Diagnostics ,Medical Imaging ,